No offense, crazyjogger, but I feel some negative
Post# of 148163
Of course people die of Covid, sadly. Nader has no way of knowing which arm of the trial the deaths are in. The DSMC recommended the trial continue after Nader said that. If there had been too many deaths in the leronlimab arm, the trial would have been halted. Period. The trial was recommended to continue meaning that the DMSC saw the trial as standing a good chance to reach its endpoints.
I can't really comment on the other two items. I personally am not holding my breath for NASDAQ until we get a positive result and then sp will increase automatically. Remember we are still waiting to hear from the MHRA for the EAM and probably the HIV BLA will be resubmitted within a month too.